Different roles of α<sub>1</sub>‐adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats

Yongzhen Zhang, Jie Yan, Kai Chen, Yao Song, Zhizhen Lü, Mingzhe Chen, Chide Han, Youyi Zhang

Clinical and Experimental Pharmacology and Physiology · 2004 · 13 citations · 30 references

Concepts

Abstract

Summary 1. Three different α 1 ‐adrenoceptor subtypes, designated α 1A , α 1B and α 1D , have been cloned and identified pharmacologically in cardiomyocytes. In vitro studies have suggested that α 1 ‐adrenoceptors play an important role in facilitating cardiac hypertrophy. However, it remains controversial as to which subtype of α 1 ‐adrenoceptors is involved in this response. In the present study, we investigated the different role of each α 1 ‐adrenoceptor subtype in mediating cardiomyocyte protein synthesis, which is a most important characteristic of cardiac hypertrophy in cultured neonatal rat cardiomyocytes. 2. Cardiomyocyte hypertrophy was monitored by the following characteristic phenotypic changes: (i) an increase in protein synthesis; (ii) an increase in total protein content; and (iii) an increase in cardiomyocyte size. 3. The role of each α 1 ‐adrenoceptor subtype in mediating cardiomyocyte protein synthesis was investigated by the effect of specific α 1 ‐adrenoceptor subtype‐selective antagonists on noradrenaline‐induced [ 3 H]‐leucine incorporation. In addition, pK B values for α 1 ‐adrenoceptor subtype‐selective antagonists were calculated and compared with the corresponding pK i values to further identify their effects. 4. Activation of α 1 ‐adrenoceptors by phenylephrine or noradrenaline in the presence of propranolol significantly increased [ 3 H]‐leucine incorporation, protein content and cell size. 5. Pre‐incubating cardiomyocytes with 5‐methyl‐urapidil, RS 17053 or WB 4101 significantly inhibited noradrenaline‐induced [ 3 H]‐leucine incorporation. However, there was no effect when cardiomyocytes were pre‐incubated with BMY 7378. The correlation coefficients between pK B values for α 1 ‐adrenoceptor subtype‐selective antagonists and pK i values obtained from cloned α 1A ‐, α 1B ‐ or α 1D ‐adrenoceptors were 0.92 ( P &lt; 0.01), 0.66 ( P &gt; 0.05) and 0.24 ( P &gt; 0.05), respectively. 6. Our results suggest that the α 1 ‐adrenoceptor is dominantly responsible for adrenergic hypertrophy of cultured cardiomyocytes in neonatal rats. The efficiency in mediating cardiomyocyte protein synthesis is α 1A &gt; α 1B ≫ α 1D .

References

30